Spago Nanomedical AB is a pharmaceutical company based in Lund that specializes in precision nanomedicine. The company is known for its development of innovative healthcare solutions aimed at improving treatment and diagnosis in the medical field. One of its key products is Tumorad®, which is designed for effective radionuclide therapy, while another significant offering is SpagoPix, which enhances MRI precision for better imaging results.
The company is recognized as an emerging leader in the field of nanomedicine, focusing on research and development to create advanced therapies, particularly targeted therapies for cancer treatment. Spago Nanomedical AB is committed to enhancing patient outcomes through the application of technology in healthcare. In addition to its product development, the company publishes financial reports and press releases to provide updates on its progress and initiatives.